1. Home
  2. EFT vs XOMA Comparison

EFT vs XOMA Comparison

Compare EFT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFT
  • XOMA
  • Stock Information
  • Founded
  • EFT 2004
  • XOMA 1981
  • Country
  • EFT United States
  • XOMA United States
  • Employees
  • EFT N/A
  • XOMA N/A
  • Industry
  • EFT Finance Companies
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFT Finance
  • XOMA Health Care
  • Exchange
  • EFT Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • EFT 327.7M
  • XOMA 330.2M
  • IPO Year
  • EFT N/A
  • XOMA N/A
  • Fundamental
  • Price
  • EFT $12.08
  • XOMA $32.47
  • Analyst Decision
  • EFT
  • XOMA Strong Buy
  • Analyst Count
  • EFT 0
  • XOMA 2
  • Target Price
  • EFT N/A
  • XOMA $69.50
  • AVG Volume (30 Days)
  • EFT 100.8K
  • XOMA 57.0K
  • Earning Date
  • EFT 01-01-0001
  • XOMA 08-13-2025
  • Dividend Yield
  • EFT 10.63%
  • XOMA N/A
  • EPS Growth
  • EFT N/A
  • XOMA N/A
  • EPS
  • EFT 1.73
  • XOMA N/A
  • Revenue
  • EFT N/A
  • XOMA $44,952,000.00
  • Revenue This Year
  • EFT N/A
  • XOMA $82.30
  • Revenue Next Year
  • EFT N/A
  • XOMA $12.59
  • P/E Ratio
  • EFT $7.62
  • XOMA N/A
  • Revenue Growth
  • EFT N/A
  • XOMA 194.98
  • 52 Week Low
  • EFT $11.10
  • XOMA $18.35
  • 52 Week High
  • EFT $13.44
  • XOMA $35.23
  • Technical
  • Relative Strength Index (RSI)
  • EFT 43.69
  • XOMA 61.79
  • Support Level
  • EFT $12.00
  • XOMA $32.60
  • Resistance Level
  • EFT $12.24
  • XOMA $34.60
  • Average True Range (ATR)
  • EFT 0.08
  • XOMA 1.82
  • MACD
  • EFT 0.01
  • XOMA 0.09
  • Stochastic Oscillator
  • EFT 63.16
  • XOMA 66.75

About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest

Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: